Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
← Back to rankings
INDP
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w low +1.3%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
nasdaq
therapeutics
indaptus
trial
announced
clinical
pharmaceuticals
results
phase
after
2023
data
york
gained
stocks
jumped
patients
decoy20
nyse
conference
INDP
Indaptus Therapeutics, Inc. Common Stock
StonvexStonvexStonvexStonvex